{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:39:47Z","timestamp":1794109187808,"version":"4.8.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biomedical Informatics"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jbi.2026.104981","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T17:05:06Z","timestamp":1768237506000},"page":"104981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["FG-DDI: Functional group-aware graph neural networks for drug\u2013drug interaction prediction"],"prefix":"10.1016","volume":"174","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8499-9920","authenticated-orcid":false,"given":"Fangyu","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0091-6919","authenticated-orcid":false,"given":"Shahadat","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jbi.2026.104981_b1","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/bcp.15970","article-title":"Drug\u2013drug interactions and the risk of adverse drug reaction-related hospital admissions in the older population","volume":"90","author":"Hughes","year":"2024","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.jbi.2026.104981_b2","doi-asserted-by":"crossref","first-page":"18964","DOI":"10.1038\/s41598-020-75888-8","article-title":"Polypharmacy, hospitalization, and mortality risk: a nationwide cohort study","volume":"10","author":"Chang","year":"2020","journal-title":"Sci. Rep."},{"issue":"37","key":"10.1016\/j.jbi.2026.104981_b3","doi-asserted-by":"crossref","first-page":"10231","DOI":"10.1073\/pnas.1612365113","article-title":"Pairwise interactions and the battle against combinatorics in multidrug therapies","volume":"113","author":"Wood","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.jbi.2026.104981_b4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.53275","article-title":"Use of clinical trial characteristics to estimate costs of new drug development","volume":"8","author":"Mulcahy","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jbi.2026.104981_b5","series-title":"Examination of clinical trial costs and barriers for drug development","author":"Plan","year":"2014"},{"issue":"1","key":"10.1016\/j.jbi.2026.104981_b6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41598-024-83090-3","article-title":"Drug discovery and mechanism prediction with explainable graph neural networks","volume":"15","author":"Wang","year":"2025","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.jbi.2026.104981_b7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10462-023-10669-z","article-title":"A review on graph neural networks for predicting synergistic drug combinations","volume":"57","author":"Besharatifard","year":"2024","journal-title":"Artif. Intell. Rev."},{"key":"10.1016\/j.jbi.2026.104981_b8","series-title":"Mr-gnn: Multi-resolution and dual graph neural network for predicting structured entity interactions","author":"Xu","year":"2019"},{"issue":"6","key":"10.1016\/j.jbi.2026.104981_b9","doi-asserted-by":"crossref","first-page":"bbab133","DOI":"10.1093\/bib\/bbab133","article-title":"SSI\u2013DDI: substructure\u2013substructure interactions for drug\u2013drug interaction prediction","volume":"22","author":"Nyamabo","year":"2021","journal-title":"Brief. Bioinform."},{"issue":"1","key":"10.1016\/j.jbi.2026.104981_b10","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac597","article-title":"DSN-DDI: an accurate and generalized framework for drug\u2013drug interaction prediction by dual-view representation learning","volume":"24","author":"Li","year":"2023","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.jbi.2026.104981_b11","doi-asserted-by":"crossref","unstructured":"K. Huang, C. Xiao, T. Hoang, L. Glass, J. Sun, Caster: Predicting drug interactions with chemical substructure representation, in: Proceedings of the AAAI Conference on Artificial Intelligence, Vol. 34, 2020, pp. 702\u2013709.","DOI":"10.1609\/aaai.v34i01.5412"},{"issue":"15","key":"10.1016\/j.jbi.2026.104981_b12","doi-asserted-by":"crossref","first-page":"8408","DOI":"10.1021\/acs.jmedchem.0c00754","article-title":"The most common functional groups in bioactive molecules and how their popularity has evolved over time","volume":"63","author":"Ertl","year":"2020","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.jbi.2026.104981_b13","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2387400","article-title":"Microbial metabolism marvels: a comprehensive review of microbial drug transformation capabilities","volume":"16","author":"Martinelli","year":"2024","journal-title":"Gut Microbes"},{"issue":"7","key":"10.1016\/j.jbi.2026.104981_b14","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3390\/biomedicines12071467","article-title":"Decoding the role of CYP450 enzymes in metabolism and disease: A comprehensive review","volume":"12","author":"Hossam Abdelmonem","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.jbi.2026.104981_b15","series-title":"Fundamentals of Aquatic Toxicology","first-page":"609","article-title":"Structure-activity relationships","author":"Lipnick","year":"2020"},{"issue":"6","key":"10.1016\/j.jbi.2026.104981_b16","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1136\/amiajnl-2012-000935","article-title":"Drug\u2014drug interaction through molecular structure similarity analysis","volume":"19","author":"Vilar","year":"2012","journal-title":"J. Am. Med. Informatics Assoc."},{"issue":"3","key":"10.1016\/j.jbi.2026.104981_b17","first-page":"391","article-title":"The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects","volume":"76","author":"Lynch","year":"2007","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.jbi.2026.104981_b18","doi-asserted-by":"crossref","DOI":"10.1109\/ACCESS.2025.3547594","article-title":"KITE-DDI: A knowledge graph integrated transformer model for accurately predicting drug-drug interaction events from drug SMILES and biomedical knowledge graph","author":"Tamir","year":"2025","journal-title":"IEEE Access"},{"key":"10.1016\/j.jbi.2026.104981_b19","doi-asserted-by":"crossref","DOI":"10.1109\/TCBB.2024.3477410","article-title":"A knowledge graph-based method for drug-drug interaction prediction with contrastive learning","author":"Zhong","year":"2024","journal-title":"IEEE\/ACM Trans. Comput. Biology Bioinform."},{"issue":"1","key":"10.1016\/j.jbi.2026.104981_b20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s43856-024-00486-y","article-title":"Accurate and interpretable drug-drug interaction prediction enabled by knowledge subgraph learning","volume":"4","author":"Wang","year":"2024","journal-title":"Commun. Med."},{"key":"10.1016\/j.jbi.2026.104981_b21","doi-asserted-by":"crossref","unstructured":"D. Wu, W. Sun, Y. He, Z. Chen, X. Luo, MKG-FENN: A multimodal knowledge graph fused end-to-end neural network for accurate drug\u2013drug interaction prediction, in: Proceedings of the AAAI Conference on Artificial Intelligence, Vol. 38, 2024, pp. 10216\u201310224.","DOI":"10.1609\/aaai.v38i9.28887"},{"key":"10.1016\/j.jbi.2026.104981_b22","series-title":"2024 IEEE International Conference on Bioinformatics and Biomedicine","first-page":"467","article-title":"MMDDI-MGPFF: Multi-modal drug representation learning with molecular graph and pharmacological feature fusion for drug-drug interaction event prediction","author":"Wang","year":"2024"},{"key":"10.1016\/j.jbi.2026.104981_b23","series-title":"DDI-GPT: Explainable prediction of drug-drug interactions using large language models enhanced with knowledge graphs","author":"Xu","year":"2024"},{"issue":"10","key":"10.1016\/j.jbi.2026.104981_b24","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.3390\/biomedicines13102355","article-title":"LLM-enhanced multimodal framework for drug\u2013drug interaction prediction","volume":"13","author":"Im","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.jbi.2026.104981_b25","article-title":"Convolutional networks on graphs for learning molecular fingerprints","volume":"28","author":"Duvenaud","year":"2015","journal-title":"Adv. Neural Inf. Process. Syst."},{"key":"10.1016\/j.jbi.2026.104981_b26","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10822-016-9938-8","article-title":"Molecular graph convolutions: moving beyond fingerprints","volume":"30","author":"Kearnes","year":"2016","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.jbi.2026.104981_b27","series-title":"Drug-drug adverse effect prediction with graph co-attention","author":"Deac","year":"2019"},{"key":"10.1016\/j.jbi.2026.104981_b28","article-title":"Graph neural networks for clinical risk prediction based on electronic health records: A survey.","volume":"151","author":"Boll","year":"2024","journal-title":"J. Biomed. Informatics"},{"key":"10.1016\/j.jbi.2026.104981_b29","series-title":"Graph attention networks","author":"Veli\u010dkovi\u0107","year":"2017"},{"issue":"1","key":"10.1016\/j.jbi.2026.104981_b30","doi-asserted-by":"crossref","first-page":"bbab441","DOI":"10.1093\/bib\/bbab441","article-title":"Drug\u2013drug interaction prediction with learnable size-adaptive molecular substructures","volume":"23","author":"Nyamabo","year":"2022","journal-title":"Brief. Bioinform."},{"issue":"29","key":"10.1016\/j.jbi.2026.104981_b31","doi-asserted-by":"crossref","first-page":"8693","DOI":"10.1039\/D2SC02023H","article-title":"Learning size-adaptive molecular substructures for explainable drug\u2013drug interaction prediction by substructure-aware graph neural network","volume":"13","author":"Yang","year":"2022","journal-title":"Chem. Sci."},{"issue":"1","key":"10.1016\/j.jbi.2026.104981_b32","doi-asserted-by":"crossref","first-page":"15590","DOI":"10.1038\/s41598-022-19999-4","article-title":"Prediction of drug-drug interaction events using graph neural networks based feature extraction","volume":"12","author":"Al-Rabeah","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbi.2026.104981_b33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2025.104852","article-title":"Multi-view based heterogeneous graph contrastive learning for drug-target interaction prediction","author":"Li","year":"2025","journal-title":"J. Biomed. Informatics"},{"issue":"6","key":"10.1016\/j.jbi.2026.104981_b34","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1021\/ci010132r","article-title":"Reoptimization of MDL keys for use in drug discovery","volume":"42","author":"Durant","year":"2002","journal-title":"J. Chem. Inf. Comput. Sci."},{"issue":"1","key":"10.1016\/j.jbi.2026.104981_b35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13321-024-00830-3","article-title":"Effectiveness of molecular fingerprints for exploring the chemical space of natural products","volume":"16","author":"Boldini","year":"2024","journal-title":"J. Cheminformatics"},{"issue":"11\u201312","key":"10.1016\/j.jbi.2026.104981_b36","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.drudis.2010.03.013","article-title":"Pharmacophore modeling and applications in drug discovery: challenges and recent advances","volume":"15","author":"Yang","year":"2010","journal-title":"Drug Discov. Today"},{"issue":"11","key":"10.1016\/j.jbi.2026.104981_b37","doi-asserted-by":"crossref","DOI":"10.1002\/minf.202000059","article-title":"Applications of the pharmacophore concept in natural product inspired drug design","volume":"39","author":"Seidel","year":"2020","journal-title":"Mol. Informatics"},{"key":"10.1016\/j.jbi.2026.104981_b38","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104361","article-title":"MedFused: A framework to discover the relationships between drug chemical functional group impacts and side effects","volume":"133","author":"Chamikara","year":"2021","journal-title":"Comput. Biol. Med."},{"issue":"3","key":"10.1016\/j.jbi.2026.104981_b39","doi-asserted-by":"crossref","first-page":"541","DOI":"10.13005\/bbra\/2659","article-title":"Frequency and importance of six functional groups that play a role in drug discovery","volume":"15","author":"Maslehat","year":"2018","journal-title":"Biosci. Biotechnol. Res. Asia"},{"key":"10.1016\/j.jbi.2026.104981_b40","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3389\/fphar.2018.01275","article-title":"QSAR-based virtual screening: advances and applications in drug discovery","volume":"9","author":"Neves","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.jbi.2026.104981_b41","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.1038\/s41467-023-41454-9","article-title":"A pharmacophore-guided deep learning approach for bioactive molecular generation","volume":"14","author":"Zhu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbi.2026.104981_b42","series-title":"SMARTS: a language for describing molecular patterns","author":"Daylight Chemical Information Systems","year":"2019"},{"issue":"20","key":"10.1016\/j.jbi.2026.104981_b43","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1021\/jm000942e","article-title":"Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties","volume":"43","author":"Ertl","year":"2000","journal-title":"J. Med. Chem."},{"issue":"26","key":"10.1016\/j.jbi.2026.104981_b44","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1021\/jm020941h","article-title":"Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis)","volume":"45","author":"Pajeva","year":"2002","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.jbi.2026.104981_b45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejps.2009.05.012","article-title":"Breast cancer resistance protein (BCRP\/ABCG2): new inhibitors and QSAR studies by a 3D linear solvation energy approach","volume":"38","author":"Nicolle","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.jbi.2026.104981_b46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090689","article-title":"In silico prediction of inhibition of promiscuous breast cancer resistance protein (BCRP\/ABCG2)","volume":"9","author":"Ding","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jbi.2026.104981_b47","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/s11095-009-9924-0","article-title":"The role of transporters in the pharmacokinetics of orally administered drugs","volume":"26","author":"Shugarts","year":"2009","journal-title":"Pharm. Res."},{"issue":"7","key":"10.1016\/j.jbi.2026.104981_b48","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2217\/pgs.11.44","article-title":"Transporter-mediated drug\u2013drug interactions","volume":"12","author":"M\u00fcller","year":"2011","journal-title":"Pharmacogenomics"},{"issue":"1","key":"10.1016\/j.jbi.2026.104981_b49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tips.2005.11.009","article-title":"Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs","volume":"27","author":"Breedveld","year":"2006","journal-title":"Trends Pharmacol. Sci."}],"container-title":["Journal of Biomedical Informatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1532046426000055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1532046426000055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T16:03:10Z","timestamp":1770048190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1532046426000055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":49,"alternative-id":["S1532046426000055"],"URL":"https:\/\/doi.org\/10.1016\/j.jbi.2026.104981","relation":{},"ISSN":["1532-0464"],"issn-type":[{"value":"1532-0464","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FG-DDI: Functional group-aware graph neural networks for drug\u2013drug interaction prediction","name":"articletitle","label":"Article Title"},{"value":"Journal of Biomedical Informatics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbi.2026.104981","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104981"}}